Table 3.
Associations Between Worsening Renal Function and 30-Day Outcomes by Type of Heart Failure
Outcome | Preserved Systolic Function (n=12,817) | Left Ventricular Systolic Dysfunction (n=7246) | ||||
---|---|---|---|---|---|---|
Unadjusted | Adjusted | P Value | Unadjusted | Adjusted | p Value | |
Inpatient costsa | 0.94 (0.81–1.09) | 0.95 (0.82–1.09) | 0.5 | 1.11 (0.95–1.30) | 1.15 (0.99–1.33) | 0.07 |
Readmissionb | 1.09 (1.00–1.19) | 1.08 (0.98–1.18) | 0.1 | 1.10 (0.96–1.27) | 1.12 (0.97–1.29) | 0.1 |
Mortalityb | 1.39 (1.16–1.66) | 1.54 (1.28–1.85) | <0.001 | 1.46 (1.18–1.80) | 1.50 (1.21–1.86) | <0.001 |
Unadjusted and adjusted values represented by cost ratios with 95% confidence intervals, based on costs excluding index hospitalization costs.
Unadjusted and adjusted values represented by hazards ratios with 95% confidence intervals.